Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2003-6-10
pubmed:abstractText
The lungs are directly exposed to higher oxygen concentrations than most other tissues. Increased oxidative stress is a significant part of the pathogenesis of obstructive lung diseases such as asthma and chronic obstructive pulmonary disease, parenchymal lung diseases (e.g., idiopathic pulmonary fibrosis and lung granulomatous diseases), and lung malignancies. Lung tissue is protected against these oxidants by a variety of antioxidant mechanisms among which the superoxide dismutases (SODs) are the only ones converting superoxide radicals to hydrogen peroxide. There are three SODs: cytosolic copper-zinc, mitochondrial manganese, and extracellular SODs. These enzymes have specific distributions and functions. Their importance in protecting lung tissue has been confirmed in transgenic and knockout animal studies. Relatively few studies have been conducted on these enzymes in the normal human lung or in human lung diseases. Most human studies suggest that there is induction of manganese SOD and, possibly, extracellular SOD during inflammatory, but not fibrotic, phases of parenchymal lung diseases and that both copper-zinc SOD and manganese SOD may be downregulated in asthmatic airways. Many previous antioxidant therapies have been disappointing, but newly characterized SOD mimetics are being shown to protect against oxidant-related lung disorders in animal models.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1073-449X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1600-19
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:12796054-Animals, pubmed-meshheading:12796054-Antioxidants, pubmed-meshheading:12796054-Biomimetics, pubmed-meshheading:12796054-Disease Models, Animal, pubmed-meshheading:12796054-Down-Regulation, pubmed-meshheading:12796054-Drug Evaluation, Preclinical, pubmed-meshheading:12796054-Free Radical Scavengers, pubmed-meshheading:12796054-Free Radicals, pubmed-meshheading:12796054-Gene Therapy, pubmed-meshheading:12796054-Humans, pubmed-meshheading:12796054-Inflammation, pubmed-meshheading:12796054-Lung, pubmed-meshheading:12796054-Lung Diseases, pubmed-meshheading:12796054-Lung Diseases, Interstitial, pubmed-meshheading:12796054-Lung Neoplasms, pubmed-meshheading:12796054-Oxidative Stress, pubmed-meshheading:12796054-Polymorphism, Genetic, pubmed-meshheading:12796054-Pulmonary Disease, Chronic Obstructive, pubmed-meshheading:12796054-Reactive Oxygen Species, pubmed-meshheading:12796054-Superoxide Dismutase
pubmed:year
2003
pubmed:articleTitle
Superoxide dismutases in the lung and human lung diseases.
pubmed:affiliation
Department of Medicine, University of Helsinki, Finland.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Review, Research Support, Non-U.S. Gov't